HCA Healthcare (HCA) Stock Forecast & Price Target

Compare

1,706 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

12 Buy

9 Hold

0 Sell

Based on 21 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$431.47

▲(1.25% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $431.47 with a high forecast of $495.00 and a low forecast of $370.00. The average price target represents a 1.25% change from the last price of $426.16.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"297":"$297","496":"$496","346.75":"$346.8","396.5":"$396.5","446.25":"$446.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":495,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$495.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":431.47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$431.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":370,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$370.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[297,346.75,396.5,446.25,496],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,426.07,431.3723076923077,436.6746153846154,441.9769230769231,447.27923076923076,452.58153846153846,457.88384615384615,463.18615384615384,468.48846153846154,473.79076923076923,479.0930769230769,484.3953846153846,489.6976923076923,{"y":495,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,426.07,426.4853846153846,426.90076923076924,427.31615384615384,427.7315384615385,428.1469230769231,428.5623076923077,428.97769230769234,429.39307692307693,429.80846153846153,430.2238461538462,430.6392307692308,431.05461538461543,{"y":431.47,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,426.07,421.75692307692304,417.44384615384615,413.1307692307692,408.8176923076923,404.50461538461536,400.19153846153847,395.8784615384615,391.56538461538463,387.2523076923077,382.9392307692308,378.62615384615384,374.31307692307695,{"y":370,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":402.18,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.31,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.98,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":298.36,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.94,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.47,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":344.44,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.76,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":380.74,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.83,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":356.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":405.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":426.07,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$495.00

Average Price Target$431.47

Lowest Price Target$370.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ann Hynes

Mizuho Securities

$425→$475

Buy

11.46%

Upside

Reiterated

10/17/25

HCA Healthcare price target raised to $475 from $425 at MizuhoHCA Healthcare price target raised to $475 from $425 at Mizuho

Lance Wilkes

Bernstein

$417

Hold

-2.15%

Downside

Reiterated

10/16/25

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$449

Buy

5.36%

Upside

Reiterated

10/15/25

HCA Healthcare (HCA) Receives a Buy from RBC Capital

Jamie Perse

Goldman Sachs

$351→$470

Buy

10.29%

Upside

Reiterated

10/15/25

Goldman Sachs Keeps Their Buy Rating on HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$415→$460

Buy

7.94%

Upside

Reiterated

10/14/25

HCA Healthcare price target raised to $460 from $415 at TruistHCA Healthcare price target raised to $460 from $415 at Truist

A.J. Rice

UBS

$438→$495

Buy

16.15%

Upside

Reiterated

10/14/25

HCA Healthcare price target raised to $495 from $438 at UBSHCA Healthcare price target raised to $495 from $438 at UBS

Andrew Mok CFA

Barclays

$445

Buy

4.42%

Upside

Reiterated

10/09/25

HCA Healthcare (HCA) Gets a Buy from Barclays

Matthew Gillmor CFA

KeyBanc

$370→$465

Buy

9.11%

Upside

Reiterated

10/08/25

HCA Healthcare price target raised to $465 from $370 at KeyBancHCA Healthcare price target raised to $465 from $370 at KeyBanc

Sarah James

Cantor Fitzgerald

$444

Buy

4.19%

Upside

Reiterated

10/07/25

Cantor Fitzgerald Sticks to Its Buy Rating for HCA Healthcare (HCA)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $444.00 price target on HCA Healthcare Inc (NYSE: HCA).

Stephen Baxter

Wells Fargo

$375→$412

Hold

-3.32%

Downside

Reiterated

10/07/25

HCA Healthcare price target raised to $412 from $375 at Wells FargoHCA Healthcare price target raised to $412 from $375 at Wells Fargo

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

10/02/25

Joanna Gajuk

Bank of America Securities

$375→$410

Hold

-3.79%

Downside

Reiterated

09/10/25

Bank of America Securities Sticks to Their Hold Rating for HCA Healthcare (HCA)

Rosa Clinessa

TR | OpenAI - 4o

$435→$452

Hold

6.06%

Upside

Downgraded

09/09/25

AI Generated ArticleAI Generated Article

Michael Ha

Robert W. Baird

$380→$423

Hold

-0.74%

Downside

Reiterated

08/14/25

HCA Healthcare price target raised to $423 from $380 at BairdHCA Healthcare price target raised to $423 from $380 at Baird

Benjamin Rossi

J.P. Morgan

$360→$370

Hold

-13.18%

Downside

Reiterated

08/04/25

HCA Healthcare (HCA) Receives a Hold from J.P. MorganJPMorgan analyst Benjamin Rossi raised the price target on HCA Healthcare Inc (NYSE: HCA) to $370.00 (from $360.00) while maintaining a Neutral rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ann Hynes

Mizuho Securities

$425→$475

Buy

11.46%

Upside

Reiterated

10/17/25

HCA Healthcare price target raised to $475 from $425 at MizuhoHCA Healthcare price target raised to $475 from $425 at Mizuho

Lance Wilkes

Bernstein

$417

Hold

-2.15%

Downside

Reiterated

10/16/25

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$449

Buy

5.36%

Upside

Reiterated

10/15/25

HCA Healthcare (HCA) Receives a Buy from RBC Capital

Jamie Perse

Goldman Sachs

$351→$470

Buy

10.29%

Upside

Reiterated

10/15/25

Goldman Sachs Keeps Their Buy Rating on HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$415→$460

Buy

7.94%

Upside

Reiterated

10/14/25

HCA Healthcare price target raised to $460 from $415 at TruistHCA Healthcare price target raised to $460 from $415 at Truist

A.J. Rice

UBS

$438→$495

Buy

16.15%

Upside

Reiterated

10/14/25

HCA Healthcare price target raised to $495 from $438 at UBSHCA Healthcare price target raised to $495 from $438 at UBS

Andrew Mok CFA

Barclays

$445

Buy

4.42%

Upside

Reiterated

10/09/25

HCA Healthcare (HCA) Gets a Buy from Barclays

Matthew Gillmor CFA

KeyBanc

$370→$465

Buy

9.11%

Upside

Reiterated

10/08/25

HCA Healthcare price target raised to $465 from $370 at KeyBancHCA Healthcare price target raised to $465 from $370 at KeyBanc

Sarah James

Cantor Fitzgerald

$444

Buy

4.19%

Upside

Reiterated

10/07/25

Cantor Fitzgerald Sticks to Its Buy Rating for HCA Healthcare (HCA)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $444.00 price target on HCA Healthcare Inc (NYSE: HCA).

Stephen Baxter

Wells Fargo

$375→$412

Hold

-3.32%

Downside

Reiterated

10/07/25

HCA Healthcare price target raised to $412 from $375 at Wells FargoHCA Healthcare price target raised to $412 from $375 at Wells Fargo

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

10/02/25

Joanna Gajuk

Bank of America Securities

$375→$410

Hold

-3.79%

Downside

Reiterated

09/10/25

Bank of America Securities Sticks to Their Hold Rating for HCA Healthcare (HCA)

Rosa Clinessa

TR | OpenAI - 4o

$435→$452

Hold

6.06%

Upside

Downgraded

09/09/25

AI Generated ArticleAI Generated Article

Michael Ha

Robert W. Baird

$380→$423

Hold

-0.74%

Downside

Reiterated

08/14/25

HCA Healthcare price target raised to $423 from $380 at BairdHCA Healthcare price target raised to $423 from $380 at Baird

Benjamin Rossi

J.P. Morgan

$360→$370

Hold

-13.18%

Downside

Reiterated

08/04/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

1 Month

xxx

Success Rate

26/38 ratings generated profit

Average Return

+4.57%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.42% of your transactions generating a profit, with an average return of +4.57% per trade.

3 Months

xxx

Success Rate

22/31 ratings generated profit

Average Return

+7.15%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 70.97% of your transactions generating a profit, with an average return of +7.15% per trade.

1 Year

Ben HendrixRBC Capital

Success Rate

22/22 ratings generated profit

Average Return

+25.49%

reiterated a buy rating 4 days ago

Copying Ben Hendrix's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.49% per trade.

2 Years

xxx

Success Rate

22/22 ratings generated profit

Average Return

+40.60%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +40.60% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 17 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. HCA average Analyst price target in the past 3 months is 431.47.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $5.72 with a range of $5.38 to $5.99. The previous quarter’s EPS was $6.84. HCA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year HCA has Preformed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $18.57B with a range of $18.36B to $18.85B. The previous quarter’s sales results were $18.61B. HCA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year HCA has Preformed in-line its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, HCA Healthcare’s 12-month average price target is 431.47.

What is HCA’s upside potential, based on the analysts’ average price target?

HCA Healthcare has 1.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

HCA Healthcare has a consensus rating of Moderate Buy which is based on 12 buy ratings, 9 hold ratings and 0 sell ratings.

What is HCA Healthcare’s price target?

The average price target for HCA Healthcare is 431.47. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $495.00 ,the lowest forecast is $370.00. The average price target represents 1.25% Increase from the current price of $426.16.

What do analysts say about HCA Healthcare?

HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts